Evidence-based medicine, critical pathways, practice guidelines, and managed care: Reflections on the prevention and care of stroke

Archives of Neurology

Volumn 53, Issue 9, 1996, Pages 867-871

  Ringel, Steven P ^a   Hughes, Richard L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTID ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; NEUROLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STROKE;

EID: 0029758802     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550090065012     Document Type: Review

References (48)

1. Hyatt HH. Protecting the medical commons: who is responsible? N Engl J Med. 1975;293:235-241.
2. Murphy DJ. Setting limits in clinical medicine. Arch Intern Med. 1994;154: 505-512.
3. Ringel SP, Recommendations for starting a clinical evaluation unit. J Outcomes Manage. 1995;2:11-16.
4. Goldstein LB, Matchar DB. Clinical assessment of stroke. JAMA. 1994;271: 1114-1120.
5. Bowen J, Yaste C. Effect of a stroke protocol in hospital costs of stroke patients. Neurology. 1994;44:1961-1964.
6. Pearson SD, Goulart-Fisher D, Lee TM. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med. 1995;1123:941-948.
7. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30:473-483.
8. lezzoni LI, Hotchkin EK, Ash AS, Shwartz M, MacKiernan Y. MedisGroups Data Bases: the impact of data collection guidelines on predicting in-hospital mortality. Med Care. 1993;31:277-283.
9. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342:1317-1322.
10. Horner RD, Matchar DB, Divine GW, Feussrier JR. Relationship between physician specialty and the selection and outcome of ischemic stroke patients. Health Serv Res. 1995;30:275-287.
11. Kaste M, Palomaki M, Sarna S. Where and how should elderly stroke patients be treated? a randomized trial. Stroke. 1995;26:249-253.
12. Langhorne P, Williams BO, Gilchrist W, Howie K. Do stroke units save lives? Lancet. 1993;342:395-398.
13. Brown RD, Evans BA, Wiebers DO, et al. Transient ischemic attack and minor ischemic stroke: an algorithm for evaluation and treatment. Mayo Clin Proc. 1994;69:1027-1039.
14. Hadorn DC, McCormick K, Diokno A. An essential algorithm approach to clinical guideline development. JAMA. 1992;267:3311-3314.
15. Insua JT, Sacks HS, Lau TS, et al. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med. 1994;121:355-362.
16. Sarasin FP, Baunameaux H, Bogousslavsky J. Asymptomatic severe carotid stenosis: immediate surgery or watchful waiting? a decision analysis. Neurology. 1995;45:2147-2153.
17. Gage BF, Cardinalli AB, Albers GW, Owens DK. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA. 1995;274:1839-1846.
18. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107:224-233.
19. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
20. Winslow CM, Solomon DM, Chassin MR, Kosecoff J, Merrick NJ, Brook RH. The appropriateness of carotid endarterectomy. N Engl J Med. 1988;318:721-727.
21. Brook RH, Park RE, Chassin MR, Solomon DH, Heesey J, Kosecoff J. Predicting the appropriate use of carotid endarterectomy, upper gastrointestinal endoscopy and coronary angiography. N Engl J Med. 1990;323:1173-1177.
22. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428.
23. Mayberg MR, Winn HR. Endarterectomy for asymptomatic carotid artery stenosis: resolving the controversy. JAMA. 1995;273:1459-1461.
24. Barnett HJM, Eliasziw M, Meldrum HE, Taylor DW. Do the tacts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology. 1996;46:603-608.
25. Gustafsson C, Aspiund K, Britton M, Norrving B, Olsson B, Marke LA. Cost-effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective. BMJ. 1992;305:1457-1460.
26. Miller VT, Pearce LA, Feinberg WM, et al. Differential effect of aspirin vs warfarin on clinical stroke types in patients with atrial fibrillation. Neurology. 1996; 46:238-240.
27. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA. 1989;262:2879-2886.
28. Holloway RG. Cost-effectiveness analysis: what is it and how will it influence neurology? Ann Neurol. In press.
29. Wilson IB, Kaplan S. Clinical practice and patients' health status: how are the two related? Med Care. 1995;33:209-214.
30. Epstein AM. The outcomes movement: will it get us where we want to go? N Engl J Med. 1990;323:266-270.
31. Asch DA, Hershey JC. Why some health policies don't make sense at the bedside. Ann Intern Med. 1995;122:846-850.
32. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the ECASS. JAMA. 1995;274:1017-1025.
33. National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581-1587.
34. Fisher M, Prichard JW, Warach S. New magnetic resonance techniques for acute ischemic stroke. JAMA. 1995;274:908-911.
35. Lanska DJ. Review criteria for hospitalization utilization for patients with cerebrovascular disease. Neurology. 1994;44:1531-1532.
36. Evidence Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA. 1992;268:2420-2425.
37. Bero L, Rennie D. The Cochrane Collaborative: preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA. 1995;274: 1935-1938
38. Menken M. Practice guidelines in neurology: will they get us where we want to go? Arch Neurol. 1992;49:193-195.
39. Wilson MC, Hayward RSA, Tunis SR, et al. Users guide to the medical literature, VIII: how to use clinical practice guidelines, B: what are the recommendations and will they help you in caring for your patients? JAMA. 1995;274: 1630-1632.
40. Berwick DM, Fineberg HV, Weinstein MC. When doctors meet numbers. Am J Med. 1981:71:991-998.
41. Gifford DR, Mittman BS, Vickrey BG. Diagnostic reasoning in neurology. Neurol Clin, 1996;14:223-238.
42. Couch JB. Educating physicians for the 21st century. In: Nash DB, ed. Future Practice Alternatives in Medicine. 2nd ed. New York, NY: Igaku-Shain Medical Publishers Inc; 1993:79-106.
43. LaPuma J, Schiedermayer D. Ethical issues in managed care and managed competition: problems and promises. In: Nash DB, ed. The Physicians Guide to Managed Care. Rockville, Md: Aspen Publishers Inc; 1994:31-60.
44. Naylor CD. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet. 1995;345:840-842.
45. Glass RM. The patient-physician relationship. JAMA. 1995;275:1478.
46. Bailit H, Federico J, McGivney W. Use of outcomes studies by a managed care organization: valuing measured treatment effects. Med Care. 1995;33:216-225.
47. Gunderson CH. The impact of new pharmaceutical agents on the cost of neurological care. Neurology. 1995;45:569-572.
48. Welch HG, Bernat JL, Magielnicki RP. Who's in charge here? J Gen Intern Med. 1994;9:450-454.